CD47 and acute myeloid leukemia: Additionally, specific immunotherapy approaches, such as CAR-T cell therapy [44], and agents like macrolimab [154,158], an anti-CD47 monoclonal antibody, and bispecific antibodies [159], are being studied as potential treatments for AML.